Liu YM - Search Results

1

Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells.

Wu WC, Liu YM, Liao YH, Hsu KC, Lien ST, Chen IC, Lai MJ, Li YH, Pan SL, Chen MC, Liou JP. Wu WC, et al. Among authors: liu ym. Eur J Med Chem. 2020 Oct 1;203:112540. doi: 10.1016/j.ejmech.2020.112540. Epub 2020 Jul 16. Eur J Med Chem. 2020. PMID: 32683166

2

Synthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivo.

Lai MJ, Huang HL, Pan SL, Liu YM, Peng CY, Lee HY, Yeh TK, Huang PH, Teng CM, Chen CS, Chuang HY, Liou JP. Lai MJ, et al. Among authors: liu ym. J Med Chem. 2012 Apr 26;55(8):3777-91. doi: 10.1021/jm300197a. Epub 2012 Apr 5. J Med Chem. 2012. PMID: 22439863 Free PMC article.

3

1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors.

Lee HY, Yang CR, Lai MJ, Huang HL, Hsieh YL, Liu YM, Yeh TK, Li YH, Mehndiratta S, Teng CM, Liou JP. Lee HY, et al. Among authors: liu ym. Chembiochem. 2013 Jul 8;14(10):1248-54. doi: 10.1002/cbic.201300201. Epub 2013 Jun 20. Chembiochem. 2013. PMID: 23788254

4

Furanylazaindoles: potent anticancer agents in vitro and in vivo.

Lee HY, Pan SL, Su MC, Liu YM, Kuo CC, Chang YT, Wu JS, Nien CY, Mehndiratta S, Chang CY, Wu SY, Lai MJ, Chang JY, Liou JP. Lee HY, et al. Among authors: liu ym. J Med Chem. 2013 Oct 24;56(20):8008-18. doi: 10.1021/jm4011115. Epub 2013 Oct 9. J Med Chem. 2013. PMID: 24106982

5

Tubulin inhibitors: a patent review.

Liu YM, Chen HL, Lee HY, Liou JP. Liu YM, et al. Expert Opin Ther Pat. 2014 Jan;24(1):69-88. doi: 10.1517/13543776.2014.859247. Epub 2013 Dec 9. Expert Opin Ther Pat. 2014. PMID: 24313741 Review.

6

Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells.

Lee HY, Tsai AC, Chen MC, Shen PJ, Cheng YC, Kuo CC, Pan SL, Liu YM, Liu JF, Yeh TK, Wang JC, Chang CY, Chang JY, Liou JP. Lee HY, et al. Among authors: liu ym, liu jf. J Med Chem. 2014 May 22;57(10):4009-22. doi: 10.1021/jm401899x. Epub 2014 May 6. J Med Chem. 2014. PMID: 24766560

7

A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin.

Wang LT, Liou JP, Li YH, Liu YM, Pan SL, Teng CM. Wang LT, et al. Among authors: liu ym. Oncotarget. 2014 Jul 30;5(14):5651-62. doi: 10.18632/oncotarget.2155. Oncotarget. 2014. PMID: 25015091 Free PMC article.

8

Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity.

Mehndiratta S, Hsieh YL, Liu YM, Wang AW, Lee HY, Liang LY, Kumar S, Teng CM, Yang CR, Liou JP. Mehndiratta S, et al. Among authors: liu ym. Eur J Med Chem. 2014 Oct 6;85:468-79. doi: 10.1016/j.ejmech.2014.08.020. Epub 2014 Aug 7. Eur J Med Chem. 2014. PMID: 25113875

9

A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression.

Wang CY, Liou JP, Tsai AC, Lai MJ, Liu YM, Lee HY, Wang JC, Pan SL, Teng CM. Wang CY, et al. Among authors: liu ym. Oncotarget. 2014 Oct 30;5(20):9838-50. doi: 10.18632/oncotarget.2451. Oncotarget. 2014. PMID: 25226613 Free PMC article.

10

1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells.

Liu YM, Lee HY, Chen CH, Lee CH, Wang LT, Pan SL, Lai MJ, Yeh TK, Liou JP. Liu YM, et al. Eur J Med Chem. 2015 Jan 7;89:320-30. doi: 10.1016/j.ejmech.2014.10.052. Epub 2014 Oct 18. Eur J Med Chem. 2015. PMID: 25462248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,797 results

Search Page